New approaches for leprosy diagnosis and treatment
Treatments studied
Part of Infections clinical trials.
This study looks at new ways to diagnose and treat leprosy. It includes patients with a more serious form of leprosy and the people who live closely with them, to help stop the spread of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a newly diagnosed patient with multibacillary leprosy (a type that affects many parts of the body) and have a bacterial index between 1 and 6.
- Or you are a close contact of a leprosy patient, such as someone who lives in the same house, shares a kitchen, or is a direct neighbor.
- You must be willing to take part in the study and sign a consent form.
- You cannot have pure nerve leprosy (only affecting nerves) or be a paucibacillary patient (mild form with few bacteria).
- Contacts must be at least 5 years old, not pregnant, not on tuberculosis or leprosy treatment, and not have liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether taking preventive antibiotics after possible contact can stop leprosy from developing. If it works, it could protect people in affected communities from getting leprosy (and possibly related infections).
This study looks at whether a specific gene (Rab 32) affects how leprosy progresses. It may help doctors better predict outcomes for people with leprosy.
This study looks at people with Hansen's disease (leprosy) in Costa Rica to understand how it affects them and how it's treated. By joining, you help researchers learn more about this condition to improve care for others.
This Phase 2 trial tests whether adding metformin to standard leprosy treatment (multidrug therapy, or MDT) helps people with multibacillary leprosy recover better and remain tolerable over 48 weeks. Participants also get monitored closely for side effects and safety issues.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
Hear when a new Leprosy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.